Cargando…

NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy

INTRODUCTION: Spinal muscular atrophy (SMA) is a fatal neurodegenerative disorder, characterized by motor neuron (MN) degeneration and severe muscular atrophy and caused by Survival of Motor Neuron (SMN) depletion. Therapies aimed at increasing SMN in patients have proven their efficiency in allevia...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Khoury, Mirella, Biondi, Olivier, Bruneteau, Gaelle, Sapaly, Delphine, Bendris, Sabrina, Bezier, Cynthia, Clerc, Zoé, Akar, Elias Abi, Weill, Laure, Eid, Assaad A., Charbonnier, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536974/ https://www.ncbi.nlm.nih.gov/pubmed/37780204 http://dx.doi.org/10.3389/fncel.2023.1242828

Ejemplares similares

Low-Intensity Running and High-Intensity Swimming Exercises Differentially Improve Energy Metabolism in Mice With Mild Spinal Muscular Atrophy
por: Houdebine, Léo, et al.
Publicado: (2019)

Mechanisms of Podocyte Injury in Diabetes: Role of Cytochrome P450 and NADPH Oxidases
por: Eid, Assaad A., et al.
Publicado: (2009)

Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy
por: Sapaly, Delphine, et al.
Publicado: (2018)

Crosstalk Between SMPDL3b and NADPH Oxidases Mediates Radiation-Induced Damage of Renal Podocytes
por: Azzam, Patrick, et al.
Publicado: (2021)

A link between agrin signalling and Ca(v)3.2 at the neuromuscular junction in spinal muscular atrophy
por: Delers, Perrine, et al.
Publicado: (2022)

NADPH Oxidase and Neurodegeneration
por: Hernandes, Marina S, et al.
Publicado: (2012)

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases
por: Youssef, Natalie, et al.
Publicado: (2021)

NADPH Oxidases and Their Role in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

NADPH Oxidases in Pain Processing
por: Kallenborn-Gerhardt, Wiebke, et al.
Publicado: (2022)

NADPH Oxidases in Aortic Aneurysms
por: Salmon, Morgan
Publicado: (2022)

The Small-Molecule Flunarizine in Spinal Muscular Atrophy Patient Fibroblasts Impacts on the Gemin Components of the SMN Complex and TDP43, an RNA-Binding Protein Relevant to Motor Neuron Diseases
por: Sapaly, Delphine, et al.
Publicado: (2020)

Natural Compounds as Modulators of NADPH Oxidases
por: Maraldi, Tullia
Publicado: (2013)

NADPH Oxidases and Mitochondria in Vascular Senescence
por: Salazar, Gloria
Publicado: (2018)

NADPH oxidases: Current aspects and tools
por: Schröder, Katrin
Publicado: (2020)

Architecture of the NADPH oxidase family of enzymes
por: Ogboo, Blessing C., et al.
Publicado: (2022)

(Poly)phenols and the regulation of NADPH oxidases
por: Fraga, Cesar G., et al.
Publicado: (2023)

NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

The NADPH Oxidase Nox4 and Aging in the Heart
por: Ago, Tetsuro, et al.
Publicado: (2010)

NADPH Oxidase and the Cardiovascular Toxicity Associated with Smoking
por: Kim, Mikyung, et al.
Publicado: (2014)

A Role for NADPH Oxidase in Antigen Presentation
por: Gardiner, Gail J., et al.
Publicado: (2013)

NADPH oxidase in brain injury and neurodegenerative disorders
por: Ma, Merry W., et al.
Publicado: (2017)

Exploiting algal NADPH oxidase for biophotovoltaic energy
por: Anderson, Alexander, et al.
Publicado: (2015)

NADPH Oxidase Deficiency: A Multisystem Approach
por: Giardino, Giuliana, et al.
Publicado: (2017)

NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease
por: Manuneedhi Cholan, Pradeep, et al.
Publicado: (2017)

The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis
por: Prieto-Bermejo, Rodrigo, et al.
Publicado: (2017)

Oxidative Stress and the Role of NADPH Oxidase in Glaucoma
por: Fan Gaskin, Jennifer C., et al.
Publicado: (2021)

The role of NADPH oxidases in infectious and inflammatory diseases
por: Taylor, Jared P., et al.
Publicado: (2021)

NADPH oxidase 2 activity in Parkinson’s disease
por: Keeney, Matthew T., et al.
Publicado: (2022)

Inhibition of NADPH Oxidases Prevents the Development of Osteoarthritis
por: Han, Jin, et al.
Publicado: (2022)

The regulation of cardiac intermediary metabolism by NADPH oxidases
por: Nabeebaccus, Adam A, et al.
Publicado: (2022)

Cross-Talk of NADPH Oxidases and Inflammation in Obesity
por: Morawietz, Henning, et al.
Publicado: (2023)

Dieckol Reduces Muscle Atrophy by Modulating Angiotensin Type II Type 1 Receptor and NADPH Oxidase in Spontaneously Hypertensive Rats
por: Oh, Seyeon, et al.
Publicado: (2021)

NADPH oxidase as a therapeutic target in Alzheimer's disease
por: Block, Michelle L
Publicado: (2008)

SH3-dependent assembly of the phagocyte NADPH oxidase
Publicado: (1994)

Involvement of NADPH oxidase in age-associated cardiac remodeling
por: Wang, Mingyi, et al.
Publicado: (2010)

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis
por: Paik, Yong-Han, et al.
Publicado: (2011)

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
por: Wind, S, et al.
Publicado: (2010)

Current status of NADPH oxidase research in cardiovascular pharmacology
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2013)

Inhibition of NADPH Oxidase by Apocynin Attenuates Progression of Atherosclerosis
por: Kinkade, Kara, et al.
Publicado: (2013)

The Importance of Myeloperoxidase in Apocynin-Mediated NADPH Oxidase Inhibition
por: de Almeida, Ana Carolina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6ibl3os9m96lpcr9r3i24c7p2j